Seeking Alpha

Inovio Pharmaceuticals (INO +2.8%) bucks a lackluster tape to trade higher after Piper Jaffray...

Inovio Pharmaceuticals (INO +2.8%) bucks a lackluster tape to trade higher after Piper Jaffray initiates coverage with an Overweight. Piper notes the company is developing a novel DNA-based vaccine platform that is demonstrating "provocative" immune responses in early studies against a multiplicity of non-viral oncology targets, as well as several infectious diseases such as HIV, HCV, HPV, and the flu. The firm adds that multiple Phase II catalysts are expected this year in its HCV and leukemia platforms.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|